Safety Profiles and Pharmacovigilance Considerations for Recently Patented / Approved Anticancer Drugs

Paolo Baldo

doi:10.2174/157489281403191028143024

ISSN: 1574-8928
E-ISSN: 2212-3970

s Safety Profiles and Pharmacovigilance Considerations for Recently Patented / Approved Anticancer Drugs
By Paolo Baldo
Source: Recent Patents on Anti-Cancer Drug Discovery, Volume 14, Issue 3, Aug 2019, p. 202 - 202
DOI: https://doi.org/10.2174/157489281403191028143024
- Available online: 01 Aug 2019

Previous Article
Table of Contents
Next Article

There is no abstract available.

Article metrics loading...

/content/journals/pra/10.2174/157489281403191028143024

2019-08-01

2025-09-11

From This Site

/content/journals/pra/10.2174/157489281403191028143024

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Full text loading...

/content/journals/pra/10.2174/157489281403191028143024

Article Type: Editorial

Most Cited Most Cited RSS feed

- Gefitinib: An Updated Review of its Role in the Cancer Management, its Nanotechnological Interventions, Recent Patents and Clinical Trials
  
  Authors: Pankaj Kumar, Bharti Mangla, Shamama Javed, Waquar Ahsan, Pankaj Musyuni, Aarif Ahsan and Geeta Aggarwal
- Research and Patents Status of Selected Phytochemicals Against Cancer: How Close and How Far?
  
  Authors: Homa Fatma and Hifzur R Siddique
- The Patent Landscape of BRAF Target and KRAS Target
  
  Authors: Hai-Long Zhang and Yongxia Li
- Understanding and Targeting the Epigenetic Regulation to Overcome EGFR-TKIs Resistance in Human Cancer
  
  Authors: Lan Sun, Lingyue Gao, Yingxi Zhao, Yuqing Wang, Qianhui Xu, Yiru Zheng, Jiali Chen, He Wang and Lihui Wang
- Matrix Metalloproteinase-2 (MMP-2): As an Essential Factor in Cancer Progression
  
  Authors: Ramakkamma Aishwarya Reddy, Magham Sai Varshini and Raman Suresh Kumar
- Curcumin Inhibits the Growth of Hepatocellular Carcinoma via the MARCH1-mediated Modulation of JAK2/STAT3 Signaling
  
  Authors: Jiaqi Su, Xianbing Liu, Xiaoyue Zhao, Hongjie Ma, Yuzhu Jiang, Xu Wang, Peiyuan Wang, Mingdong Zhao and Xuemei Hu
- Metformin Inhibits NLRP3 Inflammasome Expression and Regulates Inflammatory Microenvironment to Delay the Progression of Colorectal Cancer
  
  Authors: Gaojie Liu, Feixiang Wang, Yanlin Feng and Hongsheng Tang
- Prospective Challenges for Patenting and Clinical Trials of Anticancer Compounds from Natural Products: Coherent Review
  
  Authors: Ankit Sahoo, Ashok K. Mandal, Mayank Kumar, Khusbu Dwivedi and Deepika Singh
- Gene Expression Network and Circ_0008012 Promote Progression in MLL/AF4 Positive Acute Lymphoblastic Leukemia
  
  Authors: Yan-Lai Tang, Jia-Yin Su, Jie-Si Luo, Li-Dan Zhang, Li-Min Zheng, Cong Liang, Li-Na Wang, Yu Li, Zhong Fan, Dan-Ping Huang, Panpan Sun, Zhenhua Luo, Ning Hao Qi, Jing-Jing Lan, Xiao-Li Zhang, Li-Bin Huang and Xue-Qun Luo
- The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Previously Treated Advanced Thymic Epithelia Tumors: A Retrospective Analysis
  
  Authors: Shuo Li, Haiyan Zhou, Xiqin Zhang, Bing Bu, Rongjie Tao, Hui Zhang and Jinming Yu
More Less

s Safety Profiles and Pharmacovigilance Considerations for Recently Patented / Approved Anticancer Drugs

Most Read This Month

Most Cited Most Cited RSS feed